<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prevalence of anticardiolipin antibodies (ACLA) in sera of 49 patients having had their first <z:hpo ids='HP_0002326'>TIA</z:hpo> or <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> before 50 years of age was studied using a solid phase enzyme immunosorbent assay (ELISA) </plain></SENT>
<SENT sid="1" pm="."><plain>Five patients had IgM antibodies, eight had IgG, and three had antibodies belonging to both classes </plain></SENT>
<SENT sid="2" pm="."><plain>Although ACLA were detected in 32% of patients (95% confidence interval [CI] 19-45%), the ACLA positive group did not differ with respect to clinical characteristics and distribution of major <z:hpo ids='HP_0001297'>stroke</z:hpo> risk factor frequency from the ACLA negative group </plain></SENT>
<SENT sid="3" pm="."><plain>Further investigations are needed to establish the role of ACLA in the pathogenesis of ischemic cerebrovascular diseases </plain></SENT>
</text></document>